Treatments

Small Cell and Non-Small Cell Lung Cancer Updates

Andrew Schorr, Heather Wakelee, MD

An Expert’s Insight to Lung Cancer Treatment Developments

D. Ross Camidge, MD, PhD, Laura Levaas

Why Should Lung Cancer Patients Consider a Clinical Trial?

Jessica Wittebort, Lecia Sequist, MD, MPH - DF/HCC, Janet Freeman-Daily, Andrew Schorr

Will CAR T-Cell Therapy Benefit Lung Cancer Patients?

Jhanelle Gray, MD, Andrew Schorr

What Role Does Radiation Play in Lung Cancer Care?

Stephen A. Rosenberg, MD, MS, Jhanelle Gray, MD, Andrew Schorr

Making Strides in Small Cell Lung Cancer: An Update on Targeted Therapies

Jeffrey Crawford, MD, Andrew Schorr

Immunotherapy Update for Lung Cancer: What Kind of Patients Will Benefit?

Jeffrey Crawford, MD, Edward S. Kim, MD, Andrew Schorr

Are Side Effects More Severe for Lung Cancer Patients With Multiple Mutations?

Christine Lovly, MD, PhD

Are Targeted Therapy Side Effect Profiles in Lung Cancer Improving?

Christine Lovly, MD, PhD, Andrew Schorr

Patient Question: What Is the Next Step on My Lung Cancer Treatment Journey?

Christine Lovly, MD, PhD, Andrew Schorr

NSCLC vs. SCLC: Why Are They Treated Differently?

Laura Chow, MD, Andrew Schorr

When Is Immunotherapy An Option For Lung Cancer Patients?

Frank Griesinger, Dr.

Cancer News Sent to You

Get e-Newsletters with most current information about your health condition sent to your email!

Sign Up